Global X Scientific Beta US ETF Stock Forecast, Price & News

0.00 (0.00 %)
(As of 08/21/2020)
Today's Range
50-Day Range
52-Week Range
Volume1,602 shs
Average Volume21,875 shs
Market Capitalization$11.72 million
P/E RatioN/A
Dividend Yield3.09%
30 days | 90 days | 365 days | Advanced Chart
Receive SCIU News and Ratings via Email

Sign-up to receive the latest news and ratings for Global X Scientific Beta US ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer Global X
Fund NameGlobal X Scientific Beta US ETF
Tax ClassificationRegulated Investment Company
Inception Date5/12/2015
Fund ManagerChang Kim, James Ong, Nam To

Fund Focus

Asset ClassEquity
BenchmarkScientific Beta United States Multi-Beta Multi-Strategy Equal Risk Contribution Index
CategoryBroad Equity
FocusBroad Equity
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$11.74 million
Average Daily Volume$1,119.60

ETF Expenses

Management Fee0.28%
Other Expenses0.00%
Total Expenses0.28%
Fee Waiver-0.09%
Net Expenses0.19%

Administrator, Advisor and Custodian

AdministratorGlobal X Management Company LLC
AdvisorGlobal X Management Company LLC
CustodianBrown Brothers Harriman & Co.
DistributorSEI Investments Distribution Co.
Transfer AgentBrown Brothers Harriman & Co.
Lead Market MakerSusquehanna

speech bubbles
speech bubbles

Global X Scientific Beta US ETF (NYSEARCA:SCIU) Frequently Asked Questions

What stocks does MarketBeat like better than Global X Scientific Beta US ETF?

Wall Street analysts have given Global X Scientific Beta US ETF a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Global X Scientific Beta US ETF wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Global X Scientific Beta US ETF's stock been impacted by Coronavirus?

Global X Scientific Beta US ETF's stock was trading at $29.34 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, SCIU stock has increased by 14.1% and is now trading at $33.4801.
View which stocks have been most impacted by COVID-19

Is Global X Scientific Beta US ETF a good dividend stock?

Global X Scientific Beta US ETF pays an annual dividend of $1.04 per share and currently has a dividend yield of 3.09%.
View Global X Scientific Beta US ETF's dividend history.

Who are some of Global X Scientific Beta US ETF's key competitors?

What other stocks do shareholders of Global X Scientific Beta US ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Global X Scientific Beta US ETF investors own include Comcast (CMCSA), Exxon Mobil (XOM), salesforce.com (CRM), California Resources (CRC), Copart (CPRT), CNX Midstream Partners (CNXM), Crestwood Equity Partners (CEQP), CymaBay Therapeutics (CBAY), Barnes & Noble (BKS) and AeroVironment (AVAV).

What is Global X Scientific Beta US ETF's stock symbol?

Global X Scientific Beta US ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "SCIU."

How do I buy shares of Global X Scientific Beta US ETF?

Shares of SCIU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Global X Scientific Beta US ETF's stock price today?

One share of SCIU stock can currently be purchased for approximately $33.48.

How much money does Global X Scientific Beta US ETF make?

Global X Scientific Beta US ETF has a market capitalization of $11.72 million.

This page was last updated on 9/22/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.